What was the impact of the AI solution?

Made genomic data more accessible through a practical natural-language interface. Helped researchers explore functional relationships and accelerate discovery. Laid groundwork for future genetic disease research.

Source

Microsoft

Uniklinik RWTH Aachen builds Genolator for natural-language genomic exploration on Azure

Use case typeDecision supportUpdated 2 days ago

Uniklinik RWTH Aachen was working with large, complex datasets as they sought to understand genomic function. The team used Microsoft Azure to support large-scale model training, flexible storage, and development across the full MLOps lifecycle, enabling development of Genolator, an AI system for natural-language genomic exploration. Azure enabled researchers to build Genolator, making genomic data more accessible and helping scientists explore functional relationships, accelerate discovery, and lay the groundwork for future genetic disease research.

Organization: Uniklinik RWTH Aachen
Industry: Healthcare
Location: Germany
Published: July 2026

Reported outcomes

Strategic outcomes

Other strategic outcomeCreated a natural-language genomic exploration toolOther strategic outcomeImproved discovery workflows

Primary read

Use case focus

Showing 2 of 2

1Decision support
2Multimodal analytics

Large, complex genomic datasets require connecting multiple biological layers and supporting large-scale model training and MLOps for AI research without disrupting clinical workloads.

Developed Genolator, a multimodal AI system integrating genomic sequence representations, protein structure information, and natural language models to let researchers query coding sequences using natural language to explore potential biological processes and functions.
Used Azure for flexible compute, storage, and full MLOps lifecycle development.

Technologies

Microsoft Azure

Made genomic data more accessible through a practical natural-language interface.
Helped researchers explore functional relationships and accelerate discovery.
Laid groundwork for future genetic disease research.

Sources & evidence1

Groundedness: 5/5Type: Customer StoryPublished: Jul 11, 2026Publisher: MicrosoftEvidence: PrimaryConfidence: High

Primary source

AI-generated summary. Verify important details with the linked sources before relying on this case.

Explore related AI use cases

Customer evidence